Current Trends in Cardiac Transplantation

Critical Care Nursing Clinics of North America

Volumn 19, Issue 4, 2007, Pages 445-460

  Klein, Deborah G ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

DONOR; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGY; METHODOLOGY; PATHOLOGY; PATIENT SELECTION; POSTOPERATIVE CARE; REVIEW;

GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PATIENT SELECTION; POSTOPERATIVE CARE; TISSUE DONORS;

EID: 36048978807     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2007.08.001     Document Type: Review

References (54)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 25 8 (2006) 869-879
2. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplantation report-2004. J Heart Lung Transplant 23 7 (2004) 796-803
3. United Network for Organ Sharing. UNOS policies on allocation of thoracic organs (2004), UNOS Publications, Richmond (VA)
4. Morgan J.A., John R., Weinberg A.D., et al. Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis. Ann Thorac Surg 76 6 (2003) 1982-1987
5. Blanche C., Blanche D.A., Kearney B., et al. Heart transplantation in patients seventy years of age and older: a comparative analysis of outcome. J Thorac Cardiovasc Surg 121 3 (2001) 532-541
6. Al-khaldi A., and Robbins R.C. New directions in cardiac transplantation. Annu Rev Med 57 1 (2006) 455-471
7. Jessup M., Banner N., Brozena S., et al. Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 25 9 (2006) 1003-1023
8. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NAPSE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 40 9 (2002) 1703-1719
9. Silver H., Amnin J., Padmanabhan S., et al. Prognostic implications of increased QRS duration in patients with moderate and severe left ventricular dysfunction. Am J Cardiol 88 2 (2001) 182-185
10. Leclercq C., Cazeau S., LeBreton H., et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 32 7 (1998) 1825-1831
11. Gammie J.S., Edwards L.B., Griffin B.P., et al. Optimal timing of cardiac transplantation after ventricular assist device implantation. J Thorac Cardiovasc Surg 127 6 (2004) 1789-1799
12. Carabello B.A. Timing of surgery in mitral and aortic stenosis. Cardiol Clin 9 (1991) 229-238
13. Mehra M.R., Kobashigawa J., and Starling R. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 25 9 (2006) 1024-1042
14. Deng M.C. Cardiac transplantation. Heart 87 2 (2002) 177-184
15. Zaroff J.G., Rosengard B.R., and Armstrong W.F. Consensus conference report: maximizing use of organs recovered from cadaver donor: cardiac recommendations. March 28-29, 2001, Crystal city, VA. Circulation 106 (2002) 836-841
16. Leitz K., John R., Mancini D.M., et al. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; implications for donor selection criteria. J Am Coll Cardiol 43 9 (2004) 1553-1561
17. Fernandz J., Aranda J., Mabbot S., et al. Overseas procurement of donor hearts: ischemic time effect on post-operative outcomes. Transplant Proc 33 7-8 (2001) 3803-3804
18. Mullen J.C., Bentley M.J., Modry D.L., et al. Extended donor ischemic time and recipient outcome after orthotopic cardiac transplantation. Can J Cardiol 17 11 (2001) 421-426
19. Morgan J.A., John R., Weinberg A.D., et al. Prolonged donor ischemic time does not adversely affect long-term survival in adult patients undergoing cardiac transplantation. J Thorac Cardiovasc Surg 126 15 (2003) 1624-1633
20. Laks H., Mitropoulos F., Odim J., et al. Long-term outcomes of alternate list heart transplant patients. J Heart Lung Transplant 24 2 (2005) S20
21. Felker M., Milano C.A., Yager J.E., et al. Outcomes of alternate list strategy for heart transplantation. J Heart Lung Transplant 24 2 (2005) S163
22. Shumway N.E., Lower R.R., and Stofer R.C. Transplantation of the heart. Adv Surg 2 (1966) 265-284
23. Sievers H.H., Weyand M., Kraatz E.G., et al. An alternative technique for orthotopic cardiac transplantation with preservation of normal anatomy of the right atrium. Thorac Cardiovasc Surg 39 (1991) 70-72
24. Wade C.R., Reith K.K., Sikora J., et al. Postoperative care of the cardiac transplant recipient. Crit Care Nurs Q 27 1 (2004) 17-28
25. Jahania M.S., Mullett T.W., Sanchez J.A., et al. Acute allograft failure in thoracic organ transplantation. J Card Surg 15 (2000) 122-128
26. Taylor D.O., Edwards L.B., Boucek M.M., et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplantation report-2005. J Heart Lung Transplant 24 8 (2005) 945-955
27. Kubo S.H., Peters J.R., Knutson K.R., et al. Factors influencing the development of hypercholesterolemia after cardiac transplantation. Am J Cardiol 70 (1992) 520-526
28. Kobashigawa J.A., Katznelson S., and Laks H. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621-627
29. Sambrook P.N., Kelly P.J., Keogh A.M., et al. Bone loss after heart transplantation: a prospective study. L Heart Lung Transplant 13 (1994) 116-121
30. Muchmore J.S., Cooper D.K.C., Ye Y., et al. Prevention of loss of veterbral bone density in heart transplant patients. J Heart Lung Transplant 11 (1992) 959-964
31. Shane E., Rodino M.A., McMahon D.J., et al. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. J Heart Lung Transplant 17 (1998) 1089-1096
32. Shane E., Addesso V., Namerow P.B., et al. Alendronate versus calcitrol for the prevention of bone loss after cardiac transplantation. N Engl J Med 350 (2004) 767-776
33. Smart F.W., Naftel D.C., Costanzo M.R., et al. Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 15 (1996) 329-341
34. Walsh T.R., Guttendorf J., Dummer S., et al. the value of protective isoloation procedures in cardiac allograft recipients. Ann Thorac Surg 47 (1989) 539-545
35. Lindenfield J., Page R.L., Zolty R., et al. Drug therapy in the heart transplant recipient, part III: common medical problems. Circulation 111 (2005) 113-117
36. Rubin R.H. Prevention and treatment of cytomegalovirus disease in heart transplant patients. J Heart Lung Transplant 19 8 (2000) 731-735
37. Billingham M.E., Cary N.R.B., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. J Heart Lung Transplant 9 (1990) 587-593
38. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation of the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 11 (2005) 1710-1720
39. Veiga B.A., Crespo L.M., Domenech G.N., et al. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management. Transplant Proc 36 3 (2004) 778-779
40. Kirklin J.K., Brown R.N., Huang S.T., et al. Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis. J Heart Lung Transplant 25 3 (2006) 283-288
41. Deng M.C., Mehra M.R., Eisen H.J., et al. Cardiac allograft monitoring using a novel clinical algorithm based on peripheral leukocyte gene expression profiling. Circulation 108 (2003) 389
42. Mehra M.R., Kobashigawa J., Hunt S., et al. Molecular testing and prediction of clinical outcomes in heart transplantation: a prospective multicenter trial. J Heart Lung Transplant 23 (2004) S106
43. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 23 5 Suppl (2004) S187-S193
44. Ramzy D., Rao V., Brahm J., et al. Cardiac allograft vasculopathy: a review. Can J Surg 48 (2005) 319-321
45. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everoliumus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients. N Engl J Med 349 (2003) 847-848
46. Mancini D., Pinney S., Burkhoff D., et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 108 1 (2003) 48-53
47. Segovia J., Alonso-Pulpon L., Ortiz P., et al. Rapastat: evaluation of the role of oral sirolimus in the treatment of established graft tissue disease. A prospective randomized intravascular ultrasound study. [abstract]. J Heart Lung Transplant 23 2 Suppl (2004) S51-S52
48. Bader F.M., Kfoury A.G., Gibert E.M., et al. Percutaneous coronary interventions with stents in cardiac transplant recipients. J Heart Lung Transplant 25 3 (2006) 298-301
49. Radovancevic B., McGiffin D.C., and Kobashigawa J.A. Retransplantation in 7,290 primary transplant patients: a 10-year multi-institutional study. J Heart Lung Transplant 22 8 (2003) 862-868
50. Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 12 Suppl (1993) S328-S336
51. Opelz G., and Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant stude report. Am J Transplant 4 (2003) 222-230
52. Kaczmarek I., Deutsch M., Rohrer M., et al. HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies?. J Heart Lung Transplant 25 9 (2006) 1057-1062
53. Gray N.A., and Selzman C.H. Current status of the total artificial heart. Am Heart J 52 1 (2006) 4-10
54. King L.P., Siminoff L.A., and Meyer D.M. Health insurance and cardiac transplantation: a call for reform. J Am Coll Cardiol 45 9 (2005) 1388-1391